Literature DB >> 10716607

Investigation of endothelial hyperreactivity in the obese Zucker rat in-situ: reversal by vitamin E.

T J Andrews1, D W Laight, E E Anggård, M J Carrier.   

Abstract

The obese Zucker rat, a popular model of insulin resistance allied with oxidant stress, is associated with either normal or paradoxically enhanced endothelial vasodilator function compared with its lean litter mate. We have investigated hindquarter endothelium-dependent vasodilation in the obese Zucker rat in-situ and have examined its relationship with oxidant stress. In perfused hindquarter preparations equivalently preconstricted with phenylephrine, vasodilator responses to the endothelium-dependent agent acetylcholine (0.03-1000 pmol) were greater in obese (pD2 = 11.03+/-0.19) compared with lean (pD2 = 10.53+/-0.13) animals (P < 0.01, two-way analysis of variance). In contrast, maximal vasodilation to the nitric oxide (NO) donor sodium nitroprusside (100 nmol) was similar in obese (59.6+/-19.8%) and lean (51.9+/-2.6%) preparations (P > 0.05). However, this exaggerated vasodilator reactivity to acetylcholine in obese animals was abolished following four-week dietary supplementation with the lipophilic antioxidant vitamin E (obese pD2 = 10.74+/-0.18; lean pD2 = 10.74+/-0.08). This antioxidant-mediated effect was associated with a reduction (P < 0.02, two-way analysis of variance) and an enhancement (P < 0.01, two-way analysis of variance) in endothelium-dependent vasodilator responses in obese and lean hindlimb preparations, respectively. Our data therefore now point to a differential modulation of hindquarter endothelium-dependent vasodilation in the obese and lean Zucker rat by the prevailing oxidant tone, resulting in an agonist-stimulated endothelial vasodilator hyperreactivity in obese animals.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716607     DOI: 10.1211/0022357001773544

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  9 in total

Review 1.  Contemporary treatment of unstable angina and non-ST-segment-elevation myocardial infarction (part 1).

Authors:  Shehzad Sami; James T Willerson
Journal:  Tex Heart Inst J       Date:  2010

2.  Daily physical activity enhances reactivity to insulin in skeletal muscle arterioles of hyperphagic Otsuka Long-Evans Tokushima Fatty rats.

Authors:  Catherine R Mikus; R Scott Rector; Arturo A Arce-Esquivel; Jessica L Libla; Frank W Booth; Jamal A Ibdah; M Harold Laughlin; John P Thyfault
Journal:  J Appl Physiol (1985)       Date:  2010-07-15

3.  Prevention of hyperglycemic signal pathways in metabolic syndrome carotid artery of rats.

Authors:  Hiromi Kawai; Fengfeng Tian; Tomoko Kurata; Kentaro Deguchi; Toru Yamashita; Yoshio Omote; Syoichiro Kono; Koji Abe
Journal:  Transl Stroke Res       Date:  2012-08-14       Impact factor: 6.829

4.  Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial.

Authors:  Howard D Sesso; Julie E Buring; William G Christen; Tobias Kurth; Charlene Belanger; Jean MacFadyen; Vadim Bubes; JoAnn E Manson; Robert J Glynn; J Michael Gaziano
Journal:  JAMA       Date:  2008-11-09       Impact factor: 56.272

5.  Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity.

Authors:  Lisa M Davis; Michael Michaelides; Lawrence J Cheskin; Timothy H Moran; Susan Aja; Paul A Watkins; Zhengtong Pei; Carlo Contoreggi; Karen McCullough; Bruce Hope; Gene Jack Wang; Nora D Volkow; Panayotis K Thanos
Journal:  Neuroendocrinology       Date:  2008-11-04       Impact factor: 4.914

6.  Microvascular function in younger adults with obesity and metabolic syndrome: role of oxidative stress.

Authors:  Jacqueline K Limberg; John W Harrell; Rebecca E Johansson; Marlowe W Eldridge; Lester T Proctor; Joshua J Sebranek; William G Schrage
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-08-09       Impact factor: 4.733

7.  Hypertension in metabolic syndrome: vascular pathophysiology.

Authors:  Yolanda Mendizábal; Silvia Llorens; Eduardo Nava
Journal:  Int J Hypertens       Date:  2013-03-20       Impact factor: 2.420

8.  Effect of combination treatment of S-amlodipine with peroxisome proliferator-activated receptor agonists on metabolic and cardiovascular parameters in Zucker fa/fa rats.

Authors:  Bhagat Singh; Ganesh V Sangle; Jeya Murugan; Rinku Umrani; Subhasis Roy; Onkar Kulkarni; Arvind Semwal; Mk Unnikrishnan; Mukul Jain
Journal:  Diabetol Metab Syndr       Date:  2014-03-28       Impact factor: 3.320

9.  Dietary acid load significantly predicts 10-years survival in patients underwent coronary artery bypass grafting (CABG) surgery.

Authors:  Mahdieh Abbasalizad Farhangi; Mahdi Vajdi; Mahdi Najafi
Journal:  PLoS One       Date:  2019-10-17       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.